The CNDA Maintaines a Communication with the WHO's Representative Office in China on the Case of Changchun Changsheng Bio-tech Co's Rabies Vaccine
 
Investigation and treatment of the State Council's investigation team on Changchun Changsheng Bio-tech Co's illegal production of rabies vaccine cases is under way,and the CNDA maintains communication with the WHO's representative office in China.Changchun Changsheng Bio-tech Co began recalling the related export vaccines on July 16,and the CNDA will continue to supervise the recall.
From CFDA website